Cargando…

Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España

INTRODUCTION: The SARS-CoV-2 pandemic has posed a real challenge to health systems. In Spain, the heterogeneous distribution of the virus infection and the different health strategies have conditioned the morbidity and fatality rate. The aim of this study was to analyse the lethality of the infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Sánchez, V., Barquilla-García, A., Vitelli-Storelli, F., Segura-Fragoso, A., Ruiz-García, A., Serrano-Cumplido, A., Olmo-Quintana, V., Calderón-Montero, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Médicos de Atención Primaria (SEMERGEN). 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328631/
https://www.ncbi.nlm.nih.gov/pubmed/32709574
http://dx.doi.org/10.1016/j.semerg.2020.06.013
_version_ 1783552764286074880
author Martín-Sánchez, V.
Barquilla-García, A.
Vitelli-Storelli, F.
Segura-Fragoso, A.
Ruiz-García, A.
Serrano-Cumplido, A.
Olmo-Quintana, V.
Calderón-Montero, A.
author_facet Martín-Sánchez, V.
Barquilla-García, A.
Vitelli-Storelli, F.
Segura-Fragoso, A.
Ruiz-García, A.
Serrano-Cumplido, A.
Olmo-Quintana, V.
Calderón-Montero, A.
author_sort Martín-Sánchez, V.
collection PubMed
description INTRODUCTION: The SARS-CoV-2 pandemic has posed a real challenge to health systems. In Spain, the heterogeneous distribution of the virus infection and the different health strategies have conditioned the morbidity and fatality rate. The aim of this study was to analyse the lethality of the infection by sex and age range in the Autonomous Communities (AC) of Spain. MATERIAL AND METHODS: To perform the analysis, data were extracted from the Ministry of Health, Regional and Public Health Departments of the different AC. The infected population was estimated from the results of the ENE-COVID19 and the population registered on 1 January 2020 (INE) for the validity of the IgG antibody test with 80% sensitivity and 100% specificity. The case fatality rate (TL) (deaths/1000 estimated infected) by sex and age (< 20 years, 20-64 and ≥ 65 years) was calculated for each AC. The standardized case fatality ratio (REL) was calculated by the exact method (EPIDAT). RESULTS: The estimated prevalence of SARS-CoV-2 infection in Spain was 6% (range, 1.4% [Ceuta] - 14.1% [Community of Madrid]). The TL in Spain was 9,6/1000, ranged per AC from 1/1000 in Melilla to 26.6/1000 in La Rioja, with no correlation between case fatality and prevalence of infection. The TL was higher in men (10.2/1000, ratio 1.17 with respect to women), except in Cataluña (ratio 0.92), and especially high in those over 64 years of age in La Rioja (143.5/1000), Asturias (69.2/1000) and Basque Country (46.6/1000). Overall excess REL was found to be over 30% in La Rioja (2.91; 95% CI: 2.36-3.57), Asturias (1.51; 95% CI: 1.27-1.80), Basque Country (1.42; 95% CI: 1.31-1.54) and Extremadura (1.37; 95% CI: 1.20-1.57) and in those over 64 years in Madrid and the Canary Islands. CONCLUSIONS: SARs-CoV-2 virus infection has been very unevenly distributed in the different ACs, with notably differences in TL between ACs, particularly high in La Rioja, Asturias and the Basque Country. Is important to study the excess in TL the population over 64 years of age in the ACs of Madrid and the Canary Islands.
format Online
Article
Text
id pubmed-7328631
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Médicos de Atención Primaria (SEMERGEN).
record_format MEDLINE/PubMed
spelling pubmed-73286312020-07-01 Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España Martín-Sánchez, V. Barquilla-García, A. Vitelli-Storelli, F. Segura-Fragoso, A. Ruiz-García, A. Serrano-Cumplido, A. Olmo-Quintana, V. Calderón-Montero, A. Semergen Original INTRODUCTION: The SARS-CoV-2 pandemic has posed a real challenge to health systems. In Spain, the heterogeneous distribution of the virus infection and the different health strategies have conditioned the morbidity and fatality rate. The aim of this study was to analyse the lethality of the infection by sex and age range in the Autonomous Communities (AC) of Spain. MATERIAL AND METHODS: To perform the analysis, data were extracted from the Ministry of Health, Regional and Public Health Departments of the different AC. The infected population was estimated from the results of the ENE-COVID19 and the population registered on 1 January 2020 (INE) for the validity of the IgG antibody test with 80% sensitivity and 100% specificity. The case fatality rate (TL) (deaths/1000 estimated infected) by sex and age (< 20 years, 20-64 and ≥ 65 years) was calculated for each AC. The standardized case fatality ratio (REL) was calculated by the exact method (EPIDAT). RESULTS: The estimated prevalence of SARS-CoV-2 infection in Spain was 6% (range, 1.4% [Ceuta] - 14.1% [Community of Madrid]). The TL in Spain was 9,6/1000, ranged per AC from 1/1000 in Melilla to 26.6/1000 in La Rioja, with no correlation between case fatality and prevalence of infection. The TL was higher in men (10.2/1000, ratio 1.17 with respect to women), except in Cataluña (ratio 0.92), and especially high in those over 64 years of age in La Rioja (143.5/1000), Asturias (69.2/1000) and Basque Country (46.6/1000). Overall excess REL was found to be over 30% in La Rioja (2.91; 95% CI: 2.36-3.57), Asturias (1.51; 95% CI: 1.27-1.80), Basque Country (1.42; 95% CI: 1.31-1.54) and Extremadura (1.37; 95% CI: 1.20-1.57) and in those over 64 years in Madrid and the Canary Islands. CONCLUSIONS: SARs-CoV-2 virus infection has been very unevenly distributed in the different ACs, with notably differences in TL between ACs, particularly high in La Rioja, Asturias and the Basque Country. Is important to study the excess in TL the population over 64 years of age in the ACs of Madrid and the Canary Islands. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Médicos de Atención Primaria (SEMERGEN). 2020-08 2020-07-01 /pmc/articles/PMC7328631/ /pubmed/32709574 http://dx.doi.org/10.1016/j.semerg.2020.06.013 Text en © 2020 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original
Martín-Sánchez, V.
Barquilla-García, A.
Vitelli-Storelli, F.
Segura-Fragoso, A.
Ruiz-García, A.
Serrano-Cumplido, A.
Olmo-Quintana, V.
Calderón-Montero, A.
Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title_full Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title_fullStr Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title_full_unstemmed Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title_short Análisis de las tasas de letalidad de la infección por SARS-CoV-2 en las comunidades autónomas de España
title_sort análisis de las tasas de letalidad de la infección por sars-cov-2 en las comunidades autónomas de españa
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328631/
https://www.ncbi.nlm.nih.gov/pubmed/32709574
http://dx.doi.org/10.1016/j.semerg.2020.06.013
work_keys_str_mv AT martinsanchezv analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT barquillagarciaa analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT vitellistorellif analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT segurafragosoa analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT ruizgarciaa analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT serranocumplidoa analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT olmoquintanav analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana
AT calderonmonteroa analisisdelastasasdeletalidaddelainfeccionporsarscov2enlascomunidadesautonomasdeespana